Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.
Researchers identified common and unique characteristics of the tumor microenvironment and developed an integrated analysis structure that other researchers could utilize.